Driehaus Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Sell |
161,162
-1,008
| -0.6% | -$115K | 0.15% | 189 |
|
|
2025
Q1 | $17.1M | Sell |
162,170
-601
| -0.4% | -$63.2K | 0.16% | 183 |
|
|
2024
Q4 | $17.4M | Buy |
162,771
+67,033
| +70% | +$7.18M | 0.14% | 185 |
|
|
2024
Q3 | $9.58M | Buy |
+95,738
| New | +$9.58M | 0.08% | 234 |
|
|
2018
Q4 | – | Sell |
-25,462
| Closed | -$4.36M | – | 468 |
|
|
2018
Q3 | $4.36M | Buy |
+25,462
| New | +$4.36M | 0.13% | 199 |
|
|
2016
Q3 | – | Sell |
-26,485
| Closed | -$1.97M | – | 546 |
|
|
2016
Q2 | $1.97M | Sell |
26,485
-10,158
| -28% | -$756K | 0.07% | 268 |
|
|
2016
Q1 | $2.45M | Buy |
36,643
+8,900
| +32% | +$595K | 0.08% | 254 |
|
|
2015
Q4 | $1.88M | Buy |
+27,743
| New | +$1.88M | 0.06% | 305 |
|
|
2014
Q3 | – | Sell |
-244,826
| Closed | -$9.51M | – | 570 |
|
|
2014
Q2 | $9.51M | Buy |
244,826
+28,014
| +13% | +$1.09M | 0.31% | 72 |
|
|
2014
Q1 | $9.1M | Buy |
216,812
+15,555
| +8% | +$653K | 0.29% | 82 |
|
|
2013
Q4 | $6.6M | Buy |
+201,257
| New | +$6.6M | 0.24% | 128 |
|
|
2013
Q3 | – | Sell |
-31,831
| Closed | -$743K | – | 474 |
|
|
2013
Q2 | $743K | Buy |
+31,831
| New | +$743K | 0.03% | 359 |
|